Short Bets Against S&P 500 Healthcare Stock Rises in March; MRNA Stays Top Shorted
Piper Sandler Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $235
Morgan Stanley Maintains Align Technology(ALGN.US) With Buy Rating, Cuts Target Price to $249
Dentsply Sirona Downgraded at Morgan Stanley on Macro/ Demand Headwinds
Morgan Stanley Adjusts Align Technology Price Target to $249 From $272, Maintains Overweight Rating
Stifel Maintains Align Technology(ALGN.US) With Buy Rating, Announces Target Price $275
